Biomedical applications of microfluidic devices: a review

G Gharib, İ Bütün, Z Muganlı, G Kozalak, İ Namlı… - Biosensors, 2022 - mdpi.com
Both passive and active microfluidic chips are used in many biomedical and chemical
applications to support fluid mixing, particle manipulations, and signal detection. Passive …

Integrating organoids and organ-on-a-chip devices

Y Zhao, S Landau, S Okhovatian, C Liu… - Nature Reviews …, 2024 - nature.com
Organoids and organs-on-chips are two rapidly emerging 3D cell culture techniques that
aim to bridge the gap between in vitro 2D cultures and animal models to enable clinically …

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy

M Chehelgerdi, F Behdarvand Dehkordi… - Molecular Cancer, 2023 - Springer
The advent of iPSCs has brought about a significant transformation in stem cell research,
opening up promising avenues for advancing cancer treatment. The formation of cancer is a …

Engineered organoids for biomedical applications

NR de Barros, C Wang, S Maity, A Peirsman… - Advanced drug delivery …, 2023 - Elsevier
As miniaturized and simplified stem cell-derived 3D organ-like structures, organoids are
rapidly emerging as powerful tools for biomedical applications. With their potential for …

Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology

L Thorel, M Perréard, R Florent, J Divoux… - … & Molecular Medicine, 2024 - nature.com
Over the past decade, the emergence of patient-derived tumor organoids (PDTOs) has
broadened the repertoire of preclinical models and progressively revolutionized three …

Newly developed 3D in vitro models to study tumor–immune interaction

P Mu, S Zhou, T Lv, F Xia, L Shen, J Wan… - Journal of Experimental …, 2023 - Springer
Immunotherapy as a rapidly developing therapeutic approach has revolutionized cancer
treatment and revitalized the field of tumor immunology research. 3D in vitro models are …

3D organ-on-a-chip: The convergence of microphysiological systems and organoids

LS Baptista, C Porrini, GS Kronemberger… - Frontiers in Cell and …, 2022 - frontiersin.org
Medicine today faces the combined challenge of an increasing number of untreatable
diseases and fewer drugs reaching the clinic. While pharmaceutical companies have …

Perspectives for improving the tumor targeting of nanomedicine via the EPR effect in clinical tumors

J Kim, H Cho, DK Lim, MK Joo, K Kim - International journal of molecular …, 2023 - mdpi.com
Over the past few decades, the enhanced permeability and retention (EPR) effect of
nanomedicine has been a crucial phenomenon in targeted cancer therapy. Specifically …

Targeting KRAS in PDAC: a new way to cure it?

Q He, Z Liu, J Wang - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic cancer is one of the most intractable malignant tumors
worldwide, and is known for its refractory and poor prognosis. Pancreatic ductal …

Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies

C Bouquerel, A Dubrova, I Hofer, DTT Phan… - Lab on a Chip, 2023 - pubs.rsc.org
Over the past 15 years, the field of oncology research has witnessed significant progress in
the development of new cell culture models, such as tumor-on-chip (ToC) systems. In this …